Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Intangibles (2025)

Valion Bio has reported Intangibles over the past 1 years, most recently at $2.2 million for Q4 2025.

  • For Q4 2025, Intangibles changed N/A year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, changed N/A, while the annual FY2025 figure was $2.2 million, N/A changed from the prior year.
  • Intangibles for Q4 2025 was $2.2 million at Valion Bio, roughly flat from $2.2 million in the prior quarter.
  • Over five years, Intangibles peaked at $2.2 million in Q3 2025 and troughed at $2.2 million in Q3 2025.